$11.420
+0.081 (+0.71%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NTLA por análisis de gráficos similares
Alphio's NTLA stock price prediction model matches the current Intellia Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.54 (+1.02%). The 1-week path is $11.41 (-0.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Intellia Therapeutics Inc?
Intellia Therapeutics is not a good buy right now due to significant financial losses and analyst concerns. The current price is $11.42, which is above Barclays' price target of $8, indicating a potential downside of 30%. Additionally, the RSI is at 36.2, suggesting the stock is oversold but lacks momentum for a recovery. The company is facing regulatory challenges and insider selling has increased by 2235.78%, raising red flags about future performance.
NTLA cerró en $11.42 el Friday, tras subir +0.71%
Intellia Therapeutics Inc (NTLA) last closed at $11.42, gaining +0.71%. These facts feed the 1-day and 1-week NTLA price prediction above.
Consenso de analistas
Intellia Therapeutics Inc (NTLA): 4 comprar, 2 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Intellia Therapeutics Inc (NTLA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NTLA, ordenadas por similitud.
Análisis de estacionalidad de NTLA
Historically the probability of a positive October return for NTLA is 60.34%. October offers the highest probability of a positive month at 60.34%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.